NCT07733843

Brief Summary

The goal of this randomized clinical trial is to determine whether real-time visual feedback from three-dimensional electrical impedance tomography (3D-EIT) can improve the effects of Acapella breathing exercises in adults recovering from critical illness. 3D-EIT is a noninvasive bedside imaging method that provides real-time information about how ventilation is distributed within the lungs. Participants will be randomly assigned to one of two groups. Both groups will perform a standardized Acapella breathing exercise while 3D-EIT data and vital signs are recorded. Participants in the control group will receive routine verbal and demonstration-based breathing instructions without viewing the EIT images. Participants in the intervention group will receive the same instructions and will also view their own real-time 3D-EIT ventilation images. They will use this visual feedback to adjust their breathing with the goal of increasing ventilation in the dorsal regions of the lungs and/or achieving a more even distribution of ventilation. The main question is whether 3D-EIT-guided visual feedback results in a greater improvement in end-expiratory lung impedance (EELI) after breathing exercise compared with routine instruction alone. The study will also examine changes in regional ventilation distribution, ventilation inhomogeneity, vital signs, breathing discomfort, comfort and tolerance, achievement of the breathing-training target, and adverse events. Approximately 30 participants will be enrolled and randomly assigned in a 1:1 ratio to the two study groups.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Jul 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Jul 2026Mar 2027

First Submitted

Initial submission to the registry

July 25, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 29, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

July 31, 2026

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2027

Expected
Last Updated

July 29, 2026

Status Verified

July 1, 2026

Enrollment Period

1 day

First QC Date

July 25, 2026

Last Update Submit

July 25, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline in End-Expiratory Lung Impedance (ΔEELI)

    Change in end-expiratory lung impedance (ΔEELI) will be measured using three-dimensional electrical impedance tomography (3D-EIT). ΔEELI is defined as the EELI measured during the stable breathing period after the intervention minus the EELI measured during the stable breathing period before the intervention.

    From baseline before the intervention to 10 minutes after completion of the single Acapella training session

Secondary Outcomes (2)

  • Change From Baseline in Dorsal Lung Ventilation Proportion

    Baseline and after a 10-minute recovery period following the single Acapella training session

  • Change From Baseline in Global Inhomogeneity Index

    Baseline and after a 10-minute recovery period following the single Acapella training session

Study Arms (2)

3D-EIT Visual Biofeedback Group

EXPERIMENTAL

Participants will perform standardized Acapella breathing exercises with real-time 3D-EIT visual biofeedback in addition to routine verbal and demonstration-based instructions. Participants will view their own ventilation images and adjust their breathing to increase dorsal ventilation and/or improve ventilation homogeneity.

Device: Acapella Oscillating Positive Expiratory Pressure Breathing ExerciseDevice: Real-Time 3D Electrical Impedance Tomography Visual Biofeedback

Conventional Acapella Training Group

ACTIVE COMPARATOR

Participants will perform standardized Acapella breathing exercises under routine verbal and demonstration-based instructions without access to real-time 3D-EIT visual feedback. 3D-EIT data will still be recorded for outcome assessment.

Device: Acapella Oscillating Positive Expiratory Pressure Breathing Exercise

Interventions

Participants will perform standardized breathing exercises using an Acapella oscillating positive expiratory pressure device. Each session will consist of 3 sets of 8-10 breaths, with 10-15 seconds of rest between breaths and 1-2 minutes of rest between sets. Participants will be instructed to inhale slowly and exhale through the Acapella device. The resistance setting will be predetermined and kept unchanged throughout the session.

3D-EIT Visual Biofeedback GroupConventional Acapella Training Group

Participants in the experimental group will view their own real-time 3D electrical impedance tomography (3D-EIT) ventilation images while performing standardized Acapella breathing exercises. The visual feedback will be used to guide breathing adjustments with the aim of increasing dorsal lung ventilation and/or improving ventilation homogeneity. The 3D-EIT system will also record ventilation data for outcome assessment.

3D-EIT Visual Biofeedback Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years.
  • Adult patients in the stable recovery phase following critical illness, breathing spontaneously, alert, and able to follow instructions (suggested Richmond Agitation-Sedation Scale \[RASS\] score of -1 to +1).
  • Hemodynamically stable, with no vasopressor support or only a low and stable dose of vasopressors.
  • Receiving stable low-flow oxygen therapy or equivalent non-escalating respiratory support, without an anticipated need for escalation in the short term.
  • Clinically considered suitable for standardized Acapella breathing exercises.
  • Able and willing to provide written informed consent.

You may not qualify if:

  • Significant hemodynamic instability or clinically significant cardiac arrhythmia.
  • Untreated pneumothorax or active hemoptysis.
  • Severe chest wall skin injury or allergy to electrode materials that prevents application of the electrical impedance tomography electrodes.
  • Significant delirium or inability to understand or follow study instructions.
  • Any other condition that, in the investigator's judgment, makes the participant unsuitable for participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2026

First Posted

July 29, 2026

Study Start

July 31, 2026

Primary Completion

August 1, 2026

Study Completion (Estimated)

March 21, 2027

Last Updated

July 29, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share